Growth Hormone Deficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Growth Hormone Deficiency stocks.

Recent Signals

Date Stock Signal Type
2021-05-11 ASND Crossed Above 20 DMA Bullish
2021-05-11 ASND Bullish Engulfing Bullish
2021-05-11 ASND MACD Bearish Signal Line Cross Bearish
2021-05-11 LLY Stochastic Sell Signal Bearish
2021-05-11 LUMO NR7 Range Contraction
2021-05-11 LUMO Lower Bollinger Band Walk Weakness

Recent News for Growth Hormone Deficiency Stocks

Date Stock Title
May 11 LLY Dr Reddy's strikes licensing deal with Lilly for Baricitinib
May 11 LLY Lilly, MiNA Ink Broad RNA Deal Worth $1.25B
May 11 LLY New Strong Sell Stocks for May 11th
May 11 ASND Ascendis Pharma's TransCon PTH Provides Durable Benefit, Is Well Tolerated Even After One Year Treatment In Hypoparathyroidism
May 11 LLY Lilly, MiNA Therapeutics ink saRNA research collaboration
May 11 LLY Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
May 10 LLY Eli Lilly and Company (LLY) Sustainability Call - Slideshow
May 10 ASND Ascendis Pharma A/S Announces Preliminary 58-Week Results from Open-Label Extension of Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism Demonstrated Durable Benefit and a Well-Tolerated Safety Profile
May 10 LLY Biden's Budget May Boost These 3 Biotechs
May 10 LLY UPDATE 1-India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19
May 10 LLY Eli Lilly signs deals to boost supply of COVID-19 treatment in India
May 9 LLY Should You Buy Eli Lilly and Company (NYSE:LLY) For Its Upcoming Dividend?
May 8 LLY The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
May 7 LLY Seeking Alpha Catalyst Watch
May 6 ASND Ascendis Pharma A/S Announces Presentations for TransCon™ PTH at Upcoming Medical Conferences
May 6 ASND Should You Consider Investing in Ascendis Pharma (ASND)?
May 6 LLY United Therapeutics (UTHR) Q1 Earnings Miss, Sales Beat
May 6 LLY Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
May 6 LLY These Top 2 Healthcare Companies Are in a Race to Riches
May 6 LUMO Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q1 2021 Results - Earnings Call Transcript